Non–Small Cell Lung Cancer

By  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 6, Iss. 3, 2008-03 ,pp. : 228-228

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Relationship between icotinib hydrochloride exposure and clinical outcome in Chinese patients with advanced non–small cell lung cancer

By NiJun   LiuDong-Yang   HuBei   LiChen   JiangJi   WangHan-Ping   ZhangLi  

Cancer, Vol. 121, Iss. 17, 2015-09 ,pp. : 3146-3156

Blackwell Publishing

Access to resources Recommend Favorite

Quality of Life and Utility in Patients with Non-Small Cell Lung Cancer

By Trippoli S.   Vaiani M.   Lucioni C.   Messori A.  

PharmacoEconomics, Vol. 19, Iss. 8, 2001-01 ,pp. : 855-863

Adis International

Access to resources Recommend Favorite

The role of gefitinib in the management of Asian patients with non-small cell lung cancer

By Chang Alex Y  

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 3, 2008-03 ,pp. : 401-411

Informa Healthcare

Access to resources Recommend Favorite

Clinical next-generation sequencing in patients with non–small cell lung cancer

By Hagemann Ian S.   Devarakonda Siddhartha   Lockwood Christina M.   Spencer David H.   Guebert Kalin   Bredemeyer Andrew J.   Al-Kateb Hussam   Nguyen TuDung T.   Duncavage Eric J.   Cottrell Catherine E.   Kulkarni Shashikant   Nagarajan Rakesh   Seibert Karen   Baggstrom Maria   Waqar Saiama N.   Pfeifer John D.   Morgensztern Daniel   Govindan Ramaswamy  

Cancer, Vol. 121, Iss. 4, 2015-02 ,pp. : 631-639

Blackwell Publishing

Access to resources Recommend Favorite